Pectinase Market

Executive Summary

Pectinase Market was valued at US $336.06 million in 2021 and is projected to grow at 4.59% CAGR over the forecast period to reach US $439.96 million by 2027. Pectinase Market represented US $28.86 million opportunity over 2019-2021 and estimated to create US $103.91 million opportunity in 2027 over 2021.

Pectinase from Consainsights analyses the Pectinase Market in the Life Sciences industry over the forecast period to 2027.

Pectinase research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Pectinase segmentation includes Product, End-user and Geography.

Based on the Product, the Pectinase analysis covers PROTOPECTINASES, POLYGALACTURONASES, PECTIN LYASES, PECTINESTERASE.

In Product segment, PROTOPECTINASES segment has highest cagr growth of 4.07%.

Based on the End-user, the Pectinase analysis covers FOOD INDUSTRY, AQUACULTURE INDUSTRY, WINE-MAKING INDUSTRY, TEXTILE INDUSTRY.

In End-user segment, FOOD INDUSTRY segment has highest cagr growth of 4.07%.

Based on the region, the Pectinase analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include NOVOZYMES, GENENCOR, AMANO ENZYME, KONINKLIJKE DSM N.V., A B ENZYMES, VERENIUM, SHANDONG LONGDA, SUKAHAN BIO-TECHNOLOGY, JINYUAN BIOCHEMICAL CO LTD, SUNSON and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Product

Introduction

In 2021, PROTOPECTINASES segment has the highest revenue of US $166.63 million and is expected to grow at CAGR of 4.07% by 2027 PROTOPECTINASES segment has highest cagr growth of 4.07%.

PROTOPECTINASES

PROTOPECTINASES segment was valued at US $152.32 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $218.15 million by 2027. PROTOPECTINASES segment represented US $14.31 million opportunity over 2019-2021 and estimated to create US $51.52 million opportunity in 2027 over 2021.

POLYGALACTURONASES

POLYGALACTURONASES segment was valued at US $82.54 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $118.22 million by 2027. POLYGALACTURONASES segment represented US $7.76 million opportunity over 2019-2021 and estimated to create US $27.92 million opportunity in 2027 over 2021.

PECTIN LYASES

PECTIN LYASES segment was valued at US $64.04 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $91.71 million by 2027. PECTIN LYASES segment represented US $6.02 million opportunity over 2019-2021 and estimated to create US $21.66 million opportunity in 2027 over 2021.

PECTINESTERASE

PECTINESTERASE segment was valued at US $8.29 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $11.88 million by 2027. PECTINESTERASE segment represented US $0.78 million opportunity over 2019-2021 and estimated to create US $2.81 million opportunity in 2027 over 2021.

End-user

Introduction

In 2021, FOOD INDUSTRY segment has the highest revenue of US $161.03 million and is expected to grow at CAGR of 4.07% by 2027 FOOD INDUSTRY segment has highest cagr growth of 4.07%.

FOOD INDUSTRY

FOOD INDUSTRY segment was valued at US $147.20 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $210.82 million by 2027. FOOD INDUSTRY segment represented US $13.83 million opportunity over 2019-2021 and estimated to create US $49.79 million opportunity in 2027 over 2021.

AQUACULTURE INDUSTRY

AQUACULTURE INDUSTRY segment was valued at US $75.34 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $107.90 million by 2027. AQUACULTURE INDUSTRY segment represented US $7.08 million opportunity over 2019-2021 and estimated to create US $25.48 million opportunity in 2027 over 2021.

WINE-MAKING INDUSTRY

WINE-MAKING INDUSTRY segment was valued at US $43.52 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $62.33 million by 2027. WINE-MAKING INDUSTRY segment represented US $4.09 million opportunity over 2019-2021 and estimated to create US $14.72 million opportunity in 2027 over 2021.

TEXTILE INDUSTRY

TEXTILE INDUSTRY segment was valued at US $41.14 million in 2019 and is projected to grow at 4.07% CAGR over the forecast period to reach US $58.91 million by 2027. TEXTILE INDUSTRY segment represented US $3.87 million opportunity over 2019-2021 and estimated to create US $13.91 million opportunity in 2027 over 2021.